List of Excipients in API methotrexate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methotrexate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Accord Healthcare Inc | METHOTREXATE | methotrexate | 16729-516 | SODIUM HYDROXIDE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | LACTOSE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | MAGNESIUM STEARATE | |
| Rebel Distributors Corp | METHOTREXATE | methotrexate | 42254-110 | STARCH, CORN | |
| A-S Medication Solutions | METHOTREXATE | methotrexate | 50090-0294 | LACTOSE MONOHYDRATE | |
| A-S Medication Solutions | METHOTREXATE | methotrexate | 50090-0294 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing methotrexate
Detailed excipient profiles for methotrexate
Excipient focus: ANHYDROUS LACTOSE
methotrexate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BENZYL ALCOHOL
methotrexate drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | methotrexate | 61703-350 |
| Fresenius Kabi USA LLC | methotrexate sodium | 63323-123 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methotrexate drug variants containing CELLULOSE, MICROCRYSTALLINE
methotrexate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
methotrexate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSPOVIDONE
methotrexate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
methotrexate drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: ETHYLPARABEN
methotrexate drug variants containing ETHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing ETHYLPARABEN
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
methotrexate drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
methotrexate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
methotrexate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: GLYCERIN
methotrexate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
methotrexate drug variants containing HYDROCHLORIC ACID
methotrexate drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
methotrexate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| Bryant Ranch Prepack | methotrexate | 71335-0782 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
methotrexate drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | methotrexate sodium | 21695-111 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
methotrexate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
methotrexate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| REMEDYREPACK INC | methotrexate | 70518-3777 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
methotrexate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | methotrexate | 42254-110 |
| Dispensing Solutions Inc | methotrexate | 66336-338 |
| GenPak Solutions LLC | methotrexate sodium | 75840-111 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
methotrexate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| AvKARE | methotrexate | 42291-505 |
| Alembic Pharmaceuticals Limited | methotrexate | 46708-730 |
| Alvogen Inc | methotrexate | 47781-482 |
| A-S Medication Solutions | methotrexate | 50090-0294 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
methotrexate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| AvKARE | methotrexate | 42291-505 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN SODIUM
methotrexate drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing METHYLPARABEN SODIUM
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
methotrexate drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POLYETHYLENE GLYCOL
methotrexate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| REMEDYREPACK INC | methotrexate | 70518-3777 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
methotrexate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYSORBATE 80
methotrexate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL
methotrexate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| REMEDYREPACK INC | methotrexate | 70518-3777 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN SODIUM
methotrexate drug variants containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing PROPYLPARABEN SODIUM
Excipient focus: SILICON DIOXIDE
methotrexate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CARBONATE MONOHYDRATE
methotrexate drug variants containing SODIUM CARBONATE MONOHYDRATE
methotrexate drug variants not containing SODIUM CARBONATE MONOHYDRATE
Excipient focus: SODIUM CHLORIDE
methotrexate drug variants containing SODIUM CHLORIDE
methotrexate drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
methotrexate drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
methotrexate drug variants containing SODIUM HYDROXIDE
methotrexate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| AvKARE | methotrexate | 42291-505 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
methotrexate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Mylan Institutional Inc | methotrexate | 51079-670 |
| Golden State Medical Supply Inc | methotrexate | 51407-121 |
| Bryant Ranch Prepack | methotrexate | 71335-1118 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
methotrexate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
methotrexate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
methotrexate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methotrexate | 0378-0014 |
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| Major Pharmaceuticals | methotrexate | 0904-7141 |
| Accord Healthcare Inc | methotrexate | 16729-486 |
| Rebel Distributors Corp | methotrexate | 42254-110 |
| AvKARE | methotrexate | 42291-505 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
methotrexate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| SHORLA ONCOLOGY INC | methotrexate | 81927-204 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing SUCRALOSE
Excipient focus: TALC
methotrexate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | methotrexate | 0555-0572 |
| AvKARE Inc | methotrexate | 42291-594 |
| PD-Rx Pharmaceuticals Inc | methotrexate | 43063-439 |
| A-S Medication Solutions | methotrexate | 50090-2345 |
| A-S Medication Solutions | methotrexate | 50090-5457 |
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
methotrexate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Women's Health Inc | methotrexate | 51285-366 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
methotrexate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Parenteral Medicines Inc | methotrexate | 0703-3671 |
| Teva Parenteral Medicines Inc | methotrexate | 0703-3678 |
| Azurity Pharmaceuticals Inc | methotrexate | 52652-2001 |
| Antares Pharma Inc | methotrexate | 54436-075 |
| Medexus Pharma Inc | methotrexate | 59137-505 |
| Hospira Inc | methotrexate | 61703-350 |
| >Company | >Ingredient | >NDC |
methotrexate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
